Laura Aponte Becerra
Clinical FellowAbout
Research
Publications
2025
Exercise and Kidney Health: Core Curriculum 2026
Becerra L, Mansour S. Exercise and Kidney Health: Core Curriculum 2026. American Journal Of Kidney Diseases 2025 PMID: 41389078, PMCID: PMC12704824, DOI: 10.1053/j.ajkd.2025.09.014.Peer-Reviewed Original ResearchModerate physical activityBenefits of exercisePhysically active individualsHigh-intensity exerciseAvoidance of nonsteroidal anti-inflammatory drugsEvidence-based strategiesPhysiology of exerciseQuality of lifePhysical activityUltramarathon participationStructured exercisePhysical functionEndurance sportsHydration planActive individualsInjury diagnosisOverall healthPrevention strategiesExerciseProlonged exertionTraining practicesRisk reductionPatient counselingExcessive fluid intakeMuscle breakdownUrine Leukemia Inhibitory Factor Predicts Recovery Among Patients with Acute Interstitial Nephritis
Qian L, Becerra L, Liang C, Koval E, Shelton K, Moeckel G, Kumar D, Rosenberg A, Kuperman M, Parikh C, Xu L, Moledina D. Urine Leukemia Inhibitory Factor Predicts Recovery Among Patients with Acute Interstitial Nephritis. Journal Of The American Society Of Nephrology 2025, 36: 10.1681/asn.2025s92cpn5t. DOI: 10.1681/asn.2025s92cpn5t.Peer-Reviewed Original ResearchIndividual Treatment Effect Modeling for AKI Alerts: A Randomized Trial
Becerra L, Biswas A, Yamamoto Y, Martin M, Wilson F. Individual Treatment Effect Modeling for AKI Alerts: A Randomized Trial. Journal Of The American Society Of Nephrology 2025, 36: 10.1681/asn.2025g6skv7zc. DOI: 10.1681/asn.2025g6skv7zc.Peer-Reviewed Original ResearchTrends of preemptive kidney transplantation in lupus compared to other primary diseases leading to end stage kidney disease in the United States of America
Contreras G, Pagan J, Elfassy T, Bandes M, Bustamante N, Ortigosa-Goggins M, Becerra L, Mendoza J, Drexler Y, Alonso S, Roth D. Trends of preemptive kidney transplantation in lupus compared to other primary diseases leading to end stage kidney disease in the United States of America. Lupus 2025, 34: 775-786. PMID: 40391526, DOI: 10.1177/09612033251344189.Peer-Reviewed Original ResearchConceptsKidney allograft failurePreemptive kidney transplantationEnd-stage kidney diseasePolycystic kidney diseaseRisk of kidney allograft failureAll-Cause MortalityUnited States Renal Data SystemNon-lupusGlomerular diseaseKidney diseaseDM recipientsLupus patientsKidney transplantationRisk of all-cause mortalityNon-lupus patientsEnd stage kidney diseaseIncident ESKD patientsStage kidney diseaseCochran-Armitage testAllograft failurePrimary diseasePoor outcomeHypertensionLupusPatients
2024
Preemptive Kidney Transplantation Trends in Lupus
Contreras G, Pagan J, Elfassy T, Bandes M, Bustamante N, Goggins M, Becerra L, Mendoza J, Drexler Y, Alonso S, Roth D. Preemptive Kidney Transplantation Trends in Lupus. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024p18r0q9c. DOI: 10.1681/asn.2024p18r0q9c.Peer-Reviewed Original ResearchInfluenza B Triggering Atypical Hemolytic Uremic Syndrome (aHUS) in a Patient with Cobalamin C (CblC) Disease Carrier State and a Complement Factor H (CFH) Mutation
Becerra L, Moeckel G, Gunasekaran D. Influenza B Triggering Atypical Hemolytic Uremic Syndrome (aHUS) in a Patient with Cobalamin C (CblC) Disease Carrier State and a Complement Factor H (CFH) Mutation. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024vajywpws. DOI: 10.1681/asn.2024vajywpws.Peer-Reviewed Original ResearchMinimal Change Disease (MCD) and Human Chorionic Gonadotropin (hCG)-Mediated Thyrotoxicosis during Pregnancy
Becerra L, Moeckel G, Gondal M. Minimal Change Disease (MCD) and Human Chorionic Gonadotropin (hCG)-Mediated Thyrotoxicosis during Pregnancy. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024f2jtc080. DOI: 10.1681/asn.2024f2jtc080.Peer-Reviewed Original ResearchWCN24-330 TRENDS OF PREEMPTIVE KIDNEY TRANSPLANTATION IN PATIENTS APPROACHING END-STAGE RENAL DISEASE STRATIFIED BY PRIMARY DISEASE IN THE UNITED STATES FROM 1985 AND 2019
Martin G, Pagan J, Bustamante N, Ortigosa-Goggins M, Bandes M, Elfassy T, Becerra L, Mendoza J, Morales E, Drexler Y, Kupin W, Roth D. WCN24-330 TRENDS OF PREEMPTIVE KIDNEY TRANSPLANTATION IN PATIENTS APPROACHING END-STAGE RENAL DISEASE STRATIFIED BY PRIMARY DISEASE IN THE UNITED STATES FROM 1985 AND 2019. Kidney International Reports 2024, 9: s442-s443. DOI: 10.1016/j.ekir.2024.02.929.Peer-Reviewed Original ResearchEffects of Empagliflozin on the Progression of Chronic Kidney Disease
Aponte Becerra L, Turner JM. A commentary on: Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial. PracticeUpdate website.Commentaries, Editorials and Letters
2023
Relationships among Non-Neoplastic Histopathological Features, Kidney Function, Proteinuria, and Other Clinical Factors in Patients Undergoing Nephrectomy
Becerra L, Betancourt J, Elfassy T, Iakymenko O, Thomas D, Isaac F, Fornoni A, Zuo Y, Barisoni L, Contreras G, Mendoza J. Relationships among Non-Neoplastic Histopathological Features, Kidney Function, Proteinuria, and Other Clinical Factors in Patients Undergoing Nephrectomy. Glomerular Diseases 2023, 3: 220-229. PMID: 37915860, PMCID: PMC10616670, DOI: 10.1159/000534339.Peer-Reviewed Original ResearchLower eGFRGlobal glomerulosclerosisInterstitial fibrosisCardiovascular diseaseClinical factorsHistopathological featuresSpecific histopathological featuresGlomerular filtration rateCross-sectional analysisDipstick proteinuriaKidney functionMultivariable analysisFiltration rateKidney parenchymaOutcome measuresProteinuriaRoutine examinationHypertensionPatientsArteriosclerosisEGFRNephrectomyObesityAssociationRegression models